Aditxt signs agreement to acquire Appili Therapeutics [Seeking Alpha]
Aditxt, Inc. (ADTX)
Company Research
Source: Seeking Alpha
focused on drug development for infectious diseases and medical countermeasures. Under the agreement, Aditxt's wholly owned subsidiary, Adivir agreed to acquire all issued and outstanding Class A common shares of Appili through a court-approved plan of arrangement under Canada Business Corporations Act. Under the terms of the agreement, Adivir will acquire all of the issued and outstanding Appili shares, with each Appili shareholder receiving 0.002745004 of a share of common stock of Aditxt and $0.0467 for each Appili share held, representing total consideration per Appili share of approximately $0.0561 based on the closing price of Aditxt stock on March 28. After giving effect to the transaction, Appili Shareholders will hold approximately 19.99% of the issued and outstanding Aditxt Shares. The transaction is conditional upon Aditxt raising at least $20 million in financing prior to closing. Closing is expected to occur not later than early Q3. The arrangement agreement a
Show less
Read more
Impact Snapshot
Event Time:
ADTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADTX alerts
High impacting Aditxt, Inc. news events
Weekly update
A roundup of the hottest topics
ADTX
News
- Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co. [Yahoo! Finance]Yahoo! Finance
- Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co. [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) [Yahoo! Finance]Yahoo! Finance
- Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)Business Wire
- Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc. [Financial Post (Toronto, Ontario, Canada)]Financial Post
ADTX
Sec Filings
- 4/16/24 - Form 10-K
- 4/12/24 - Form 8-K
- 4/4/24 - Form 8-K
- ADTX's page on the SEC website